Beta Glucan Market Trends

Over the course of the projected period, increasing product demand in functional food and animal feed applications is anticipated to be a major market driver. The global demand for functional foods is being driven in large part by the increase in chronic diseases and the growing elderly population. Low immunity levels are more common in developing nations, particularly in children and women. The aforementioned elements, along with growing consumer health consciousness, are anticipated to fuel demand for immunity-boosting substances like the product. Consumers are increasingly choosing preventive programmes over after-treatment drugs.

Over the anticipated period, product advancements, particularly in the nutrition sector, are anticipated to drive up demand for nutraceuticals and pharmaceuticals containing yeast beta-glucan.

In 2021, the U.S. held the greatest volume share of more than 75.0% in the North American market, and it is anticipated that it would continue to hold the lead throughout the projection period. Over the anticipated period, it is anticipated that high consumer expenditure on functional food products and dietary supplements will increase product demand in the nation. The substance was one of the chemicals that received the most attention during the epidemic due to its immune-boosting qualities.

According to research conducted in 2020 at Unité de Glycobiologie Structurale et Fonctionnelle (UGSF), it aids in enhancing immune defence prior to a patient contracting respiratory virus infections, particularly SARS-CoV-2.

The rapid growth of the nutraceutical industry worldwide helped to boost the global market. By including functional foods and other dietary supplements in their daily diets, consumers are adopting creative strategies to meet their nutritional needs. The market for these food products with added nutrients is quickly expanding among consumers who are adopting a healthy diet, such as athletes, gym attendees, and other health-conscious individuals.

Manufacturers of nutraceuticals are focusing on developing a variety of B-glucan-infused natural supplements that will especially enhance the body's immune and digestive systems. The use of B-glucan in manufacturing has expanded over the past few years as a result of the expanding global popularity of the "go-green trend" and plant-derived food ingredients. The future expansion of B-glucan in the global market is guaranteed by the anticipation of the current environment and the growing need for such nutrient-infused supplements.

Thus, driving the Beta-Glucan market revenue.

The increasing global focus on health and wellness is driving demand for natural ingredients, including beta-glucan. Consumers are becoming more conscious of their dietary choices, seeking products that enhance immune function and overall health. This trend is particularly evident in the Global Beta-Glucan Market Industry, where beta-glucan is recognized for its potential health benefits, such as cholesterol reduction and immune support. As a result, the market is projected to reach 1.49 USD Billion in 2024, reflecting a growing preference for functional foods and supplements that incorporate beta-glucan.

The Global Beta-Glucan Market Industry is projected to experience substantial growth, with estimates indicating a market value of 1.49 USD Billion in 2024 and a potential increase to 2.55 USD Billion by 2035. This growth trajectory suggests a strong interest in beta-glucan as a functional ingredient across various sectors. The anticipated compound annual growth rate (CAGR) of 5.03% from 2025 to 2035 further underscores the market's potential, reflecting the increasing incorporation of beta-glucan in health-oriented products and the expanding consumer base seeking its benefits.

The regulatory landscape is becoming increasingly favorable for the use of beta-glucan in food and dietary supplements. Regulatory bodies are recognizing the health claims associated with beta-glucan, which is bolstering consumer confidence and encouraging manufacturers to incorporate it into their products. This supportive environment is a key driver for the Global Beta-Glucan Market Industry, as it facilitates research and development efforts aimed at exploring new applications. As the market matures, it is likely that more products will emerge, further enhancing the growth trajectory of the industry.

Ongoing research and development activities are playing a crucial role in advancing the applications of beta-glucan. Scientific studies continue to explore its health benefits, leading to new insights that could expand its use in various sectors, including pharmaceuticals and nutraceuticals. This emphasis on R&D is a driving force within the Global Beta-Glucan Market Industry, as it fosters innovation and encourages investment in new product development. As the understanding of beta-glucan's properties deepens, it is anticipated that the market will witness an influx of novel applications and formulations.

The rising demand for functional foods is a significant driver of the Global Beta-Glucan Market Industry. Consumers are increasingly seeking foods that offer health benefits beyond basic nutrition, and beta-glucan fits this criterion well. Its ability to support heart health and immune function aligns with current dietary trends. This demand is projected to sustain a compound annual growth rate (CAGR) of 5.03% from 2025 to 2035, indicating robust growth potential. As manufacturers respond to this trend by developing innovative products, the market for beta-glucan is likely to flourish.

Beta-glucan is increasingly being utilized in various food and beverage applications, including bakery products, dairy, and functional beverages. This diversification is contributing to the growth of the Global Beta-Glucan Market Industry, as manufacturers seek to enhance the nutritional profile of their offerings. For instance, the incorporation of beta-glucan in cereals and snacks is appealing to health-conscious consumers. The market is expected to expand significantly, with projections indicating a rise to 2.55 USD Billion by 2035, driven by innovative product formulations that leverage the health benefits of beta-glucan.

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Beta-Glucan market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Beta-Glucan Industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Beta-Glucan Industry to benefit clients and increase the market sector. In recent years, the Beta-Glucan Industry has offered some of the most significant advantages to medicine. Major players in the Beta-Glucan market, including Kerry Group plc., Givaudan SA, Koninklijke DSM N.V., Euglena Co. Ltd, Biotec Pharmacon ASA, Tate & Lyle plc., Lesaffre Group, Kemin Industries, Inc., ABF Ingredients, Super Beta Glucan, and Garuda International, Inc., are attempting to increase market demand by investing in research and development operations.

Kemin Industries Inc. (Kemin) produces and distributes substances linked to human nutrition and animal health. Its product line includes, among other things, enzymes, probiotics, carotenoids, natural extracts, mould inhibitors, forage preservatives, toxin binders, liquid antibacterial formulations, and antioxidant formulations. These goods are used in a variety of sectors, such as biofuels, personal care, commercial greenhouses, pet food technology, rendering, dietary ingredients, food technologies, and animal nutrition and health. Kemin Industry will be expanding its production facility in December 2022.

The company's dedication to innovation and sustainability in animal nutrition and health is shown in Kemin's decision to expand its Cavriago production facility.

The mission of Royal DSM NV (DSM), a science-based company, is to identify environmental, social, and economic challenges and opportunities, seize those opportunities to have a long-lasting positive impact on people and the environment, and then build growth through sustainable, profitable expansion. The business makes speciality plastics, fiber and resin solutions, nutritional lipids, carotenoids, vitamins, and other components. From agriculture byproducts and biochemicals, the company creates materials for renewable energy and medicinal devices.

The launch of an integrated food and beverage operating structure, which brings together three aspects of DSM's nutrition business—Food Specialties, Hydrocolloids, and a portion of its Nutritional Products Group—was announced by the company in January 2022.